Log in to save to my catalogue

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c2f7c922836941d782022c8f8f942952

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objectives
The relation of serum androgens and the development of prostate cancer (PCa) is subject of debate. Lower total testosterone (TT) levels have been associated with increased PCa detection and worse pathological features after treatment. However, data from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) and Prostate Cance...

Alternative Titles

Full title

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c2f7c922836941d782022c8f8f942952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c2f7c922836941d782022c8f8f942952

Other Identifiers

ISSN

2688-4526

E-ISSN

2688-4526

DOI

10.1002/bco2.156

How to access this item